Kathyleen Volpe Hedrick, MS ARNP | |
500 Vonderburg Drive, Ste 115w, Brandon, FL 33511-5969 | |
(813) 685-0306 | |
(813) 651-1026 |
Full Name | Kathyleen Volpe Hedrick |
---|---|
Gender | Female |
Speciality | Dermatology |
Location | 500 Vonderburg Drive, Brandon, Florida |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437184785 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
364SP0808X | Clinical Nurse Specialist - Psychiatric/mental Health | ARNA1298102 (Florida) | Secondary |
207N00000X | Dermatology | ARNP1298102 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kathyleen Volpe Hedrick, MS ARNP 4651 Van Dyke Rd, Lutz, FL 33558-4880 Ph: (813) 321-1786 | Kathyleen Volpe Hedrick, MS ARNP 500 Vonderburg Drive, Ste 115w, Brandon, FL 33511-5969 Ph: (813) 685-0306 |
News Archive
The good news is that there may soon be a new weapon in the battle against the so-called "worst" cancer - cancer of the pancreas. A multidisciplinary group of investigators from the UCLA School of Dentistry, the David Geffen School of Medicine at UCLA, the UCLA School of Public Health and UCLA's Jonsson Comprehensive Cancer Center has demonstrated the usefulness of salivary diagnostics in the effort to find and fight the disease.
A team of researchers at the University of Toronto has discovered a method of assembling "building blocks" of gold nanoparticles as the vehicle to deliver cancer medications or cancer-identifying markers directly into cancerous tumors.
Cincinnati Business Courier: Ohio Gov. Ted Strickland has signed a bill that will extend the state's mini-COBRA program from 12 to 15 months for small-business employees, according to a report in Columbus Business First (3/1).
Kentucky health officials are considering restrictions on the number of cancer-fighting drugs Medicaid patients may receive without prior approval, a move designed to contain costs in the health care program for the poor and disabled. The possibility of creating a non-preferred list of oral oncology drugs — pills that replace intravenous chemotherapy drugs — that Medicaid won't pay for without prior approval has raised questions from patient advocates and those who treat cancer patients.
› Verified 6 days ago